Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
2022 · Nature Medicine · 325 citations
https://doi.org/10.1038/s41591-022-01829-9
L
Lisa Salvador
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
1.4K
Citations
15
h-index
16
i10-index
Lisa Salvador is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cardiac Valve Diseases and Treatments & Reproductive Biology and Fertility. The author has an h-index of 15, co-authored 26 publications.
Papers by this author
worksFollicle-stimulating Hormone Activates Extracellular Signal-regulated Kinase but Not Extracellular Signal-regulated Kinase Kinase through a 100-kDa Phosphotyrosine Phosphatase
2003 · Journal of Biological Chemistry · 132 citations
https://doi.org/10.1074/jbc.m203901200
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
2023 · Cancer Cell · 72 citations
https://doi.org/10.1016/j.ccell.2023.03.010
Neuronal Microtubule-associated Protein 2D Is a Dual A-kinase Anchoring Protein Expressed in Rat Ovarian Granulosa Cells
2004 · Journal of Biological Chemistry · 24 citations
https://doi.org/10.1074/jbc.m402980200
Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies
2018 · Human Gene Therapy Methods · 22 citations
https://doi.org/10.1089/hgtb.2018.131
Differential expression of circulating markers of calcific aortic valve disease
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.10003268
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat